A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 305 participants.

Also called NCT04669041

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 305 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04669041
Other papers using this trial's data
  • Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial Advances in therapy, 2023-12 DOI, PubMed 37770770, PMC10611639 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04669041. Randomized; triple masking; primary purpose treatment. Start 2020-12-08 (actual); primary completion 2022-06-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy
Acronym
ROZEL
Condition
Hypercholesterolemia
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
SPC ezetimibe/rosuvastatin
Intervention (Drug)
Rosuvastatin active capsule
Intervention (Drug)
Placebo
Intervention (Drug)
Placebo
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct04669041
Content hash
089280f0b73e2f5bc8e06538b96b0e03b7afa6cde6c0209088b784395ee95401